2012 will be a very important year for Geron. With a new CEO who is a deal maker. The share price should go higher. The four phase two trials end in Dec of 2012 and results will be reported then. The GRN 1005 will be in phase two soon if that trial goes well it could get fast tracked. GRNOPC1 in phase one trial, using stem cells to treat patients with spinal cord injuries, any good results would send the share price to the moon. I've been buying all the way down from $4 to $2 avg share price is now $3.80. I will sell a few shares on big prices moves.
Good luck in this rigged casino,
Lee
No comments:
Post a Comment